Oliver Wiedow

Chief Executive Officer presso PROTEO, INC.

66 anni

Health Technology

Consumer Services

Profilo

Oliver Wiedow is the founder of tiakis BIOTECH AG, a company founded in 2000, where he currently holds the title of Chairman-Supervisory Board.
He is also the founder of Proteo, Inc., a company founded in 2000, where he currently holds the titles of President, Chief Executive Officer, CFO & Director.
Additionally, Dr. Wiedow is the founder of the University of Kiel, where he holds the title of Professor-Dermatology since 1985.

Posizioni attive di Oliver Wiedow

Società	Posizione	Inizio
PROTEO, INC.	Chief Executive Officer	15/11/2018
tiakis BIOTECH AG tiakis BIOTECH AG BiotechnologyHealth Technology Tiakis BIOTECH AG is a German company that operates as a next generation tissue protective therapeutic technology company. The company is based in Kiel, Germany. Tiakis BIOTECH AG was founded in 2000 by Oliver Wiedow.	Founder	23/05/2012
University of Kiel	Corporate Officer/Principal	01/01/1999

Tutte le posizioni attive di Oliver Wiedow

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Oliver Wiedow

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Proteo, Inc. Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA.	Health Technology
tiakis BIOTECH AG tiakis BIOTECH AG BiotechnologyHealth Technology Tiakis BIOTECH AG is a German company that operates as a next generation tissue protective therapeutic technology company. The company is based in Kiel, Germany. Tiakis BIOTECH AG was founded in 2000 by Oliver Wiedow.	Health Technology